Jay Flatley is the founder of Zymergen. Zymergen has raised $1.5B in total funding. Latest round: IPO. Backed by SoftBank, Baillie Gifford.
Jay Flatley served as the Chairman and acting CEO of Zymergen, a biotechnology company based in Emeryville, California. The company focused on applying genomics and machine learning to research and design chemical-producing genetically modified organisms, aiming to create products typically made from petrochemicals. Zymergen attracted over $1 billion in venture funding before going public with a market capitalization of $3 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library